Investors may have been surprised today to find that the ticker symbol for Watson Pharmaceuticals, a well-known stalwart of the generic pharmaceutical industry, is now defunct. However, there's no need to panic: The company has simply changed its name to Actavis (NYSE:AGN). Our health-care analyst Max Macaluso goes into the details behind the rebranding in this video.
Editor's note: One look at the statistics box that enters the video at 19 seconds reveals the timeliness of this report -- this ticker is so new that the company's information hasn't yet been added to our database! The information listed there is incorrect, and the Fool regrets the error.
Max Macaluso, Ph.D. has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
2 Reasons Why Allergan Stock Plunged in 2017
Allergan's shares fell off a cliff last year. Can it rebound in 2018?
Allergan Stock Downgraded: What You Need to Know
Allergan's valuation depends heavily on its growth -- but that growth could be at risk.
Allergan Keeps Heading Lower. Is It Time to Buy?
Allergan's stock slips for the third straight month in October.